Infectious Diseases
News from the FDA/CDC
20% of U.S. COVID-19 deaths were aged 20-64 years
Preliminary data also demonstrate that severe illness leading to hospitalization, including ICU admission and death, can occur in adults of any...
News
Real-world shortages not addressed in new COVID-19 guidance
WHO provides up-to-date guidance on COVID-19 treatment, but real-world ingenuity will be needed to tackle thorny issues surrounding this disease...
News
Lopinavir-ritonavir trial results ‘disappointing’ for severe COVID-19
But patients in the lopinavir/ritonavir group had a shorter stay in the intensive care unit than did those in the standard-care group.
News
AGA and colleague societies issue clinical insights for COVID-19
Screening patients, personal protection, procedure postponement, and special precautions with infected patients are discussed.
News
Patients with COVID-19 may face risk for liver injury
Mechanisms of damage remain unclear, but could include virus-, immune-, or drug-induced injury.
News
COVID-19 will test medical supply stocks
“In the matter of a week or two...I think we’ll get a feel for whether or not we really have enough of the supplies that it takes,” said Dr....
News
ACP outlines guide for COVID-19 telehealth coding, billing
Also included are tips on handling staff absences and information on allowed technology and services.
News
Inactivated flu vaccine succeeds among autoimmune rheumatic disease patients
Safety and effectiveness data support use of inactivated flu vaccine for individuals with autoimmune rheumatic diseases.
Article
Clinicians petition government for national quarantine
The petition was started by an apolitical Facebook group to focus attention on what members see as the most critical issues for clinicians.
News
COVID-19: U.S. cardiology groups reaffirm continued use of RAAS-active drugs
Experts give ACE inhibitors and ARBs, cornerstones of cardiology therapy, a thumbs up despite a hypothetical adverse COVID-19 effect.